Vasopressin increases human risky cooperative behavior

Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2051-6. doi: 10.1073/pnas.1518825113. Epub 2016 Feb 8.

Abstract

The history of humankind is an epic of cooperation, which is ubiquitous across societies and increasing in scale. Much human cooperation occurs where it is risky to cooperate for mutual benefit because successful cooperation depends on a sufficient level of cooperation by others. Here we show that arginine vasopressin (AVP), a neuropeptide that mediates complex mammalian social behaviors such as pair bonding, social recognition and aggression causally increases humans' willingness to engage in risky, mutually beneficial cooperation. In two double-blind experiments, male participants received either AVP or placebo intranasally and made decisions with financial consequences in the "Stag hunt" cooperation game. AVP increases humans' willingness to cooperate. That increase is not due to an increase in the general willingness to bear risks or to altruistically help others. Using functional brain imaging, we show that, when subjects make the risky Stag choice, AVP down-regulates the BOLD signal in the left dorsolateral prefrontal cortex (dlPFC), a risk-integration region, and increases the left dlPFC functional connectivity with the ventral pallidum, an AVP receptor-rich region previously associated with AVP-mediated social reward processing in mammals. These findings show a previously unidentified causal role for AVP in social approach behavior in humans, as established by animal research.

Keywords: cooperation; fMRI; intranasal administration; neuroeconomics; vasopressin.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Arginine Vasopressin* / administration & dosage
  • Arginine Vasopressin* / pharmacokinetics
  • Basal Forebrain / metabolism
  • Cooperative Behavior*
  • Humans
  • Male
  • Neuroimaging*
  • Risk-Taking*

Substances

  • Arginine Vasopressin